Gene Query: XPO4

Dataset Description Geneva Score
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 42.58
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 41.53
Gene expression analysis of the impact of TDP-43 knockout in human cells. 38.99
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 36.68
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 35.48
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 32.11
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 29.57
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 27.0
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 26.79
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 24.5
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 24.5
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 22.44
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 22.09
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 20.91
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 20.91
TGF-β regulation of miRNA expression in pancreatic cancer 19.84
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 19.68
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 19.68
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 19.65
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 19.25
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 18.69
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 18.69
The landscape of alternative splicing in aggressive prostate cancers 17.53
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 17.52
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 17.37
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 17.24
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 17.18
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 16.67
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 16.44
LncRNA-GAS5 negative regulation of YAP-target genes expression 15.9
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 15.85
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 15.85
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 15.63
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 15.58
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 15.58
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 15.53
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 15.47
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 15.16
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 14.91
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 14.35
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 14.02
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 13.86
Region-specific Innate Antiviral Responses of the Human Epididymis 13.85
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 13.68
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 13.66
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 13.65
Human embryonic stem cells in E8 and AKIT culture medium 13.65
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 13.6
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 13.6
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 13.48
RNAseq Analysis in glioblastoma cells treated with Mepazine 13.39
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 13.35
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 13.3
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 12.84
RNAseq Study in CC-671 Treated Cal-51 Cells 12.57
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 12.48
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 12.46
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 12.41
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 12.4
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 12.4
Developmental stage specific chromosome architecture in human erythroid cells 12.4
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 12.4
LNCaP treated with iBET 12.28
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 12.27
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 12.21
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 12.16
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 12.12
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 12.12
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 12.1
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 12.1
12.09
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 12.02
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 11.91
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 11.79
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.7
RIG-I and MDA5 fRIP during KSHV lytic reactivation 11.66
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 11.6
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 11.51
R430: A potent inbibitor of DNA and RNA viruses 11.43
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 11.33
MYCL and EP400 are required for Max and MCPyV mediated gene activation 11.29
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 11.26
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 11.2
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 11.07
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 11.03
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 11.01
Impact of dieldrin on transcription in Jurkat T cells 10.9
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 10.88
Systematic discovery of endogenous human ribonucleoprotein complexes 10.84
Transcriptome of human white and brown adipose tissue biopsies 10.8
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 10.76
Nrf2 regulated genes in A549 cells 10.71
Identification of Nrf2 regulated genes by RNA sequencing 10.71
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 10.66
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 10.61
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 10.53
MYC dependent mRNA translation shapes gene expression and cell biology 10.47
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 10.42
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 10.27
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 10.25
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 10.19
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 10.17
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 10.16
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 10.12
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 10.09
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 10.0
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 9.96
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 9.87
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.84
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 9.69
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 9.69
Lysine benzoylation is a novel histone mark [RNA-seq] 9.69
Lysine benzoylation is a novel histone mark 9.69
A transcriptome-wide divergence in protein translation scales with LIN28B expression 9.66
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.65
Transcriptomic analyssis following EHMT1/2 inhibition 9.5
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.44
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.4
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 9.3
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 9.22
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 9.15
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 9.06
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 9.06
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 9.04
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 9.0
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 9.0
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 9.0
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 9.0
Human cell line and subcutaneous tumor 8.98
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 8.97
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.96
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 8.88
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 8.86
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 8.86
Genes significantly down or Up-regulated upon RNF219 knockdown 8.86
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 8.83
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 8.78
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.71
Uridylation by TUT4 and TUT7 marks mRNA for degradation 8.71
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.68
Pharmacologic inhibition of STAT5 in AML 8.66
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.66
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.66
The effect of PPARG inhibition on human angiomyolipoma cells 8.62
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.61
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.61
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 8.56
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 8.5
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 8.48
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.42
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.4
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.37
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.35
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.34
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 8.31
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 8.31
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 8.31
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 8.3
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.23
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.23
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 8.16
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.12
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 8.12
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.06
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 8.04
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.02
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.02
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.02
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 8.02
SLIGRL-induced gene expression changes in NHEK cells 8.0
RNA-seq analysis of RALD iPSCs after in vitro differentiation 7.98
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.88
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.88
RNA-seq analysis of differentiating human erythroblasts 7.87
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.82
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.79
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.74
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 7.72
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 7.68
Cleavage Factor Im as a key regulator of 3’ UTR length 7.67
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 7.66
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 7.65
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 7.58
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 7.57
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 7.55
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 7.51
Targeting MTHFD2 in Acute Myeloid Leukemia 7.5
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.49
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.41
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.35
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 7.35
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 7.35
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 7.33
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.33
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.25
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.25
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.25
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 7.23
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 7.23
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 7.23
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 7.23
Seletive inhibition of CDK9 in DLBCL cell lines 7.23
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.22
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 7.2
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 7.19
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.14
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 7.11
Transcription control by the ENL YEATS domain in acute leukemia 7.1
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 7.1
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 7.08
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.03
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 7.02
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 6.98
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 6.96
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 6.91
Identification of HOXB13 target genes responsive to BET inhibitors 6.91
A role for ZNF598 in post-transcriptional gene regulation 6.89
EGR1-controlled transcriptome of T HESCs 6.87
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.84
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 6.84
Effect of PBK knockdown on C4-2 cell transcriptome 6.81
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.8
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 6.74
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.71
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 6.65
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 6.65
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.64
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.63
Total RNA-seq in ALL-SIL upon JQ1 inhibition 6.62
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 6.61
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 6.59
RNA-seq of RKO cells with cTAZ KO or putback 6.57
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 6.56
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.56
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 6.52
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 6.47
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 6.47
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 6.47
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 6.42
FBXW7 modulates stress response by post-translational modification of HSF1 6.37
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 6.37
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 6.35
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 6.31
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 6.31
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 6.3
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 6.26
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 6.24
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.23
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.21
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.19
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 6.17
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 6.15
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.14
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.14
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.08
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 6.08
MicroRNA-125a-5p overexpression in human macrophages 6.08
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.06
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 6.06
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.03
Determination of tRNA aminoacylation levels by high throughput sequencing 6.01
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 5.99
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.98
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.93
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.93
Transcriptome analysis upon C6orf203 silencing 5.89
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.87
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.87
In vitro modeling of human germ cell development using pluripotent stem cells 5.86
CDK4/6 inhibitor resistance in prostate cancer 5.86
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.85
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.85
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 5.8
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 5.77
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 5.77
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 5.74
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 5.74
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 5.74
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 5.73
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.65
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.64
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 5.61
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.59
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 5.55
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.51
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.51
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.43
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 5.36
Downregulation of DDX5/DDX17 and REST 5.34
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.34
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 5.33
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 5.31
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 5.29
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 5.27
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 5.27
A map of gene expression in neutrophil-like cell lines 5.14
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 5.12
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 5.11
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 5.05
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.01
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.01
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 5.01
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 5.01
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.92
Electronic cigarettes 4.87
LIN28A Over-expression RNAseq 4.87
Gene expression analysis upon mtDNA depletion 4.86
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.86
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.83
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.82
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.82
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 4.73
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.68
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.68
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.61
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 4.61
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 4.59
Induced DNA demethylation, genome instability and transcription 4.59
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 4.59
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 4.54
Regulation of poly(A) tail and translation during the somatic cell cycle 4.5
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.5
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 4.48
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.46
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.46
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.45
Transcriptomic analysis of LSD1 4.43
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 4.37
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.34
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 4.13
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.12
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.12
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.08
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.0
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.9
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.88
The cohesin release factor WAPL restricts chromatin loop extension. 3.87
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.87
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.83
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.83
RNA-seq of naive and primed ES cells (NHSM) 3.79
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 3.78
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.76
The transcriptome effect of overexpressing EZH2 in MCF7 3.75
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 3.74
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.7
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.69
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.68
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.64
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.64
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 3.61
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 3.61
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.44
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.39
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.38
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.38
Gene expression profiling of leukemia cells following asparagine depletion 3.33
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.27
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.19
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.14
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.06
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 3.06
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.06
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.06
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 3.05
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 3.02
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 2.96
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.96
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.92
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.91
Identifying the molecular mode of action of itraconazole in colorectal cancer 2.9
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.86
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.79
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.78
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.76
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.73
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.73
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.72
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.66
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.64
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.62
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.58
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.51
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.5
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.46
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.42
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.42
Human Treg IFNg/IL-10 subpopulations 2.33
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.26
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.25
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.25
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.25
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.22
TAF1 is critical for AE driven leukemogenesis 2.22
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.22
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.17
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 2.11
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.1
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.09
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.05
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.04
HBEC-shp53-PCHD7 2.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.02
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.01
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.0
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.99
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.99
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.98
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.97
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.95
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.95
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.95
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 1.92
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.9
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.89
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 1.87
RNA seq with AML (NB4) cells upon FTO inhibition 1.79
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.78
Transcriptomes in healthy and CHB fetal hearts 1.73
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.72
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.68
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.65
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.65
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.64
RNA-seq analysis of control and Myc-induced U2OS cells 1.62
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.6
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.59
The contribution of Alu exons to the human proteome 1.56
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.54
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.51
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.51
Transposon-based construction of strand-specific RNA-seq libraries 1.48
Dilated cardiomyopathy vs Myocarditis 1.44
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.41
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.4
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.39
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.36
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.26
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.18
Transcriptomic analysis of frontal fibrosing alopecia 1.17
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.13
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.11
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.11
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.08
Engineering Patient-Specific Tissue Implants 1.02
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.01
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.01
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.01
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.98
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.97
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.97
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.94
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.93
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.86
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.86
Transcriptome-wide modulation of splicing by the exon junction complex 0.82
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.73
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.73
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.72
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.72
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.68
Mitochondrial dsRNA triggers antiviral signalling in humans 0.62
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.62
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.59
The role of the Calcium-Sensing receptor in colorectal cancer 0.56
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.55
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.52
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.5
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.5
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.5
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.5
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.5
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.49
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.45
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.44
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.44
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.38
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.38
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.38
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.36
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.36
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.33
Modulation of nonsense-mediated decay by rapamycin 0.32
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.3
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.25
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.25
A code of mono-phosphorylation modulates the function of RB. 0.22
Identification of expressed and conserved human non-coding RNAs 0.19
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.18
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.13
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.11
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.04
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.03
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.02
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.02
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation